The European Medicines Agency (EMA) just shared new details about its December cyberattack.
The attack compromised data and documents of companies who were candidates for the Pfizer and BioNTech COVID-19 vaccine.
SecureWorld previously reported on this attack, where you can find more information. Now, let's look at what is new.
EMA update on cyberattack
In the recent update, EMA revealed that some of the information accessed by hackers has been published online. And yes, it involved data related to the pandemic:
"The ongoing investigation of the cyberattack on EMA revealed that some of the unlawfully accessed documents related to COVID-19 medicines and vaccines belonging to third parties have been leaked on the internet. Necessary action is being taken by the law enforcement authorities.
The Agency continues to fully support the criminal investigation into the data breach and to notify any additional entities and individuals whose documents and personal data may have been subject to unauthorized access."
The Agency and the European medicines regulatory network remain fully functional, and say timelines related to the evaluation and approval of COVID-19 medicines remain on track.